Cargando…
Diversification of circulating and tumor‐infiltrating plasmacytoid DCs towards the P3 (CD80(+) PDL1(−))‐pDC subset negatively correlated with clinical outcomes in melanoma patients
OBJECTIVES: Plasmacytoid DCs (pDCs) play a critical yet enigmatic role in antitumor immunity through their pleiotropic immunomodulatory functions. Despite proof of pDC diversity in several physiological or pathological contexts, pDCs have been studied as a whole population so far in cancer. The asse...
Autores principales: | Sosa Cuevas, Eleonora, Bendriss‐Vermare, Nathalie, Mouret, Stephane, De Fraipont, Florence, Charles, Julie, Valladeau‐Guilemond, Jenny, Chaperot, Laurence, Aspord, Caroline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063720/ https://www.ncbi.nlm.nih.gov/pubmed/35517992 http://dx.doi.org/10.1002/cti2.1382 |
Ejemplares similares
-
BDCA1(+) cDC2s, BDCA2(+) pDCs and BDCA3(+) cDC1s reveal distinct pathophysiologic features and impact on clinical outcomes in melanoma patients
por: Sosa Cuevas, Eleonora, et al.
Publicado: (2020) -
Hepatitis B virus exploits C‐type lectin receptors to hijack cDC1s, cDC2s and pDCs
por: Ouaguia, Laurissa, et al.
Publicado: (2020) -
Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients
por: Sosa Cuevas, Eleonora, et al.
Publicado: (2022) -
pDC therapy induces recovery from EAE by recruiting endogenous pDC to sites of CNS inflammation
por: Duraes, Fernanda V., et al.
Publicado: (2016) -
Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection
por: Ouaguia, Laurissa, et al.
Publicado: (2019)